← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
76	76 Pluri PLUR $12.3M	31	-2	-6%	$721K
77	ATNX 77 DELISTED Athenex, Inc. Common Stock ATNX	30	-23	-43%	$2.43M
78	78 Capricor Therapeutics CAPR $399M	30	0	0%	$10.3M
79	79 Marker Therapeutics MRKR $18M	30	-17	-36%	$1.41M
80	80 PharmaCyte Biotech PMCB $3.76M	29	-1	-3%	$10.2M
81	81 TScan Therapeutics TCRX $16.1M	28	0	0%	$20.3M
82	82 Calidi Biotherapeutics CLDI $2.21M	26	+3	+13%	$40.6M
83	BLCM 83 DELISTED Bellicum Pharmaceuticals, Inc. BLCM	25	-8	-24%	$470K
84	84 Senti Biosciences Holdings SNTI $7.38M	24	-2	-8%	$14.3M
85	85 BioCardia BCDA $13.8M	23	-2	-8%	$4.09M
86	PTE 86 DELISTED PolarityTE, Inc. Common Stock PTE	23	-9	-28%	$310K
87	87 Benitec Biopharma BNTC $284M	21	-4	-16%	$2.44M
88	88 Candel Therapeutics CADL $655M	21	0	0%	$7.44M
89	89 DELISTED Orgenesis Inc. Common Stock ORGS	20	+1	+5%	$2.4M
90	90 DELISTED Scorpius Holdings, Inc. SCPX	20	-4	-17%	$2.05M
91	91 Enlivex Ltd ENLV $4.49M	19	-2	-10%	$1.24M
92	ACHL 92 DELISTED Achilles Therapeutics ACHL	18	-5	-22%	$19.4M
93	93 Genprex GNPX $1.8M	18	0	0%	$5.42M
94	94 Imunon IMNN $5.78M	18	-3	-14%	$513K
95	95 IN8bio INAB $11.5M	17	+2	+13%	$1.78M
96	96 Creative Medical Technology CELZ $6.04M	15	-3	-17%	$176K
97	97 DELISTED CERo Therapeutics CERO	15	-30	-67%	$12.5M
98	FRLN 98 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	15	-2	-12%	$16.9M
99	LGVN 99 Longeveron LGVN $4.53M	15	0	0%	$1.13M
100	100 BioRestorative Therapies BRTX $2.13M	14	+1	+8%	$1.02M